Clinical Research Directory

Inclusion Criteria: * Is 60 years or older at the date of inclusion; * Has a confirmed diagnosis of atrophic dry age related macular degeneration with an atrophy size of at least 3 optic disc diameters in the study eye; * Has best corrected visual acuity of logMAR 1.3 (20/400) or worse in the study eye measured by ETDRS; * Has a central scotoma in the study eye with no perception at 0 dB on MP-1 micro-perimetry scale in the visual field covering the central 7 degrees (+/-3.5 degrees) and maximum 20% perception in the remaining visual field covering the central 12 degrees (+/- 6 degrees); * Meets one of the following criteria in the non-study eye: * Visual acuity of 20/200 (logMAR 1.0) or worse and an atrophy size \<8mm2 * Visual acuity of 20/160 (logMAR 0.9) or worse and an atrophy size ≥8mm2 and ≤12.5 mm2 * Visual acuity of 20/100 (logMAR 0.7) or worse and an atrophy size \>12.5 mm2 * Has a refraction of study eye between -3 and + 4 (limits included) for patients with IOL (there is no refraction criteria for phakic patients); * Understands and accepts the obligation to present for all schedule follow-up visits; * Patient signed informed consent. Main Exclusion Criteria: * Has cataract in the study ; * Has an aphakic study eye; * Has no light perception in the study eye; * Has a history of choroidal neovascularization in either eye; * Has any disease (other than study allowed diseases) or condition that affects retinal function of the study eye * Has an implanted telescope in one eye; * Has any disease or condition that prevents adequate examination of the study * Has a corneal endothelial cell count of less than 1000 cells/mm² in the study eye * Suffers from nystagmus or other ocular motility disorders; * Has any disease or condition that precludes the understanding or communication of the informed consent, study requirements or test protocols * Has a history of epileptic seizure; * Has a history of chronic or recurrent infection or inflammation that would preclude participation in the study; * Presents with hypotony or hypertony in the study eye; * Has another active implanted device; * Has active cancer or a history of intraocular, optic nerve or brain cancer and metastasis; * Is an immune-suppressed subject; * Is carrier of multi-resistant microorganisms; * Is receiving anticoagulation therapy that cannot be adapted to allow eye surgery; * Is participating in another investigational drug or device study that may interfere with the present study; * Has recurrent or chronic inflammations or infections; * Has a severe psychological disorder; * Does not have the mental capacity to legally sign the informed consent; * Has severe renal, cardiac, hepatic, etc. organ diseases; * Has head dimensions that are incompatible with the Visual Interface; * Has too high and unrealistic expectation; Detailed patient criteria will be verified by the study doctor.